AAAAAA

   
Results: 1-14 |
Results: 14
Autologous stem cell transplantation for follicular lymphoma: no benefit for early transplant?
Authors: Seyfarth, B Kuse, R Sonnen, R Glass, B Schmitz, N Dreger, P
Citation: B. Seyfarth et al., Autologous stem cell transplantation for follicular lymphoma: no benefit for early transplant?, ANN HEMATOL, 80(7), 2001, pp. 398-405
Which factors render cost-covering lump-sum charging difficult for the treatment of patients with acute leukemias?
Authors: Kuse, R Colberg, H Marbe, W Kodalle, O Kalmar, P Lohfert, C
Citation: R. Kuse et al., Which factors render cost-covering lump-sum charging difficult for the treatment of patients with acute leukemias?, ONKOLOGIE, 24(3), 2001, pp. 292-294
Fludarabine plus cyclophosphamide is an efficient treatment for advanced chronic lymphocytic leukaemia, (CLL): results of a phase II study of the German CLL Study Group
Authors: Hallek, M Schmitt, B Wilhelm, M Busch, R Krober, A Fostitsch, HP Sezer, O Herold, M Knauf, W Wendtner, CM Kuse, R Freund, M Franke, A Schriever, F Nerl, C Dohner, H Thiel, E Hiddemann, W Brittinger, G Emmerich, B
Citation: M. Hallek et al., Fludarabine plus cyclophosphamide is an efficient treatment for advanced chronic lymphocytic leukaemia, (CLL): results of a phase II study of the German CLL Study Group, BR J HAEM, 114(2), 2001, pp. 342-348
Donor lymphocyte infusion enhances remission status in patients with persistent disease after allografting for multiple myeloma
Authors: Kroger, N Kruger, W Renges, H Zabelina, T Stute, N Jung, R Wittkowsky, G Kuse, R Zander, AR
Citation: N. Kroger et al., Donor lymphocyte infusion enhances remission status in patients with persistent disease after allografting for multiple myeloma, BR J HAEM, 112(2), 2001, pp. 421-423
Rituximab therapy of patients with B-cell chronic lymphocytic leukemia
Authors: Huhn, D von Schilling, C Wilhelm, M Ho, AD Hallek, M Kuse, R Knauf, W Riedel, U Hinke, A Srock, S Serke, S Peschel, C Emmerich, B
Citation: D. Huhn et al., Rituximab therapy of patients with B-cell chronic lymphocytic leukemia, BLOOD, 98(5), 2001, pp. 1326-1331
The 10.000/mu l morning trigger for prophylactic platelet transfusion is safe: Prospective experience in 411 AML patients
Authors: Wandt, H Frank, M Denzel, T Aulitzky, W Bodenstein, H Brack, N Duerk, H Engberding, R Fauser, A Geer, T Germann, B Gramatzki, M Kaesberger, J Kisro, J Knigge, O Kochling, G Kuse, R Link, H Neubauer, A Ohl, S Pfluger, R Saal, J Schakel, U Schalk, K Schmidt, H Soucek, S Wagner, T Wilms, K Winter, R Ehninger, G
Citation: H. Wandt et al., The 10.000/mu l morning trigger for prophylactic platelet transfusion is safe: Prospective experience in 411 AML patients, HEMAT BLOOD, 40, 2001, pp. 488-490
Treatment of acute myeloid leukemia in the elderly patient
Authors: Kuse, R
Citation: R. Kuse, Treatment of acute myeloid leukemia in the elderly patient, DEUT MED WO, 125(9), 2000, pp. 272-272
Multicenter phase II study of oral idarubicin in treated and untreated patients with B-chronic lymphocytic leukemia
Authors: Gahn, B Brittinger, G Dolken, G Dohner, H Emmerich, B Franke, A Freund, M Huber, C Kuse, R Scholten, T Hiddemann, W
Citation: B. Gahn et al., Multicenter phase II study of oral idarubicin in treated and untreated patients with B-chronic lymphocytic leukemia, LEUK LYMPH, 37(1-2), 2000, pp. 169-173
Dose-dependent effect of etoposide in combination with busulfan plus cyclophosphamide as conditioning for stem cell transplantation in patients with acute myeloid leukemia
Authors: Kroger, N Zabelina, T Sonnenberg, S Kruger, W Renges, H Stute, N Finkenstein, F Mayer, U Holstein, K Fiedler, W Colberg, H Sonnen, R Kuse, R Braumann, D Metzner, B del Valle, F Erttmann, R Kabisch, H Zander, AR
Citation: N. Kroger et al., Dose-dependent effect of etoposide in combination with busulfan plus cyclophosphamide as conditioning for stem cell transplantation in patients with acute myeloid leukemia, BONE MAR TR, 26(7), 2000, pp. 711-716
Origin of stroma cells in long-term bone marrow cultures from patients with acute myeloid leukemia
Authors: Zhang, W Knieling, G Vohwinkel, G Martinez, T Kuse, R Hossfeld, DK Duhrsen, U
Citation: W. Zhang et al., Origin of stroma cells in long-term bone marrow cultures from patients with acute myeloid leukemia, ANN HEMATOL, 78(7), 1999, pp. 305-314
Jumping translocation of 1q as the sole aberration in a case of follicularlymphoma
Authors: Rosenwald, A Ott, G Katzenberger, T Siebert, R Kalla, J Kuse, R Ott, MM Muller-Hermelink, HK Schlegelberger, B
Citation: A. Rosenwald et al., Jumping translocation of 1q as the sole aberration in a case of follicularlymphoma, CANC GENET, 108(1), 1999, pp. 53-56
Myeloablative radiochemotherapy followed by reinfusion of purged autologous stem cells for Waldenstrom's macroglobulinaemia
Authors: Dreger, P Glass, B Kuse, R Sonnen, R von Neuhoff, N Bolouri, H Kneba, M Schmitz, N
Citation: P. Dreger et al., Myeloablative radiochemotherapy followed by reinfusion of purged autologous stem cells for Waldenstrom's macroglobulinaemia, BR J HAEM, 106(1), 1999, pp. 115-118
Efficacy of further attempts to mobilize CD34+peripheral stem cells with alternative procedures after primary failure
Authors: Kroger, N Rauhoft, C Zeller, W Renges, H Hassan, HT Kruger, W Schuch, G Wacker-Backhaus, G Colberg, H Kuse, R Gutensohn, K Loliger, C Zander, AR
Citation: N. Kroger et al., Efficacy of further attempts to mobilize CD34+peripheral stem cells with alternative procedures after primary failure, ACT HAEMAT, 102(3), 1999, pp. 144-147
Intensified conditioning regimen in bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia
Authors: Kroger, N Kruger, W Wacker-Backhaus, G Hegewisch-Becker, S Stockschlader, M Fuchs, N Russmann, B Renges, H Durken, M Bielack, S de Wit, M Schuch, G Bartels, H Braumann, D Kuse, R Kabisch, H Erttmann, R Zander, AR
Citation: N. Kroger et al., Intensified conditioning regimen in bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia, BONE MAR TR, 22(11), 1998, pp. 1029-1033
Risultati: 1-14 |